{"entity":{"type":"insider","cik":"0001287535","url":"/insider/0001287535","json_url":"/insider/0001287535.json","name":"JACKSON MICHAEL K","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":6,"first":"2009-12-10","last":"2012-03-27","span_basis":"filed_date"},"name_variants":[{"name":"JACKSON MICHAEL K","source":"filing","n_filings":6,"first_seen":"2009-12-10","last_seen":"2012-03-27"}],"transactions":[{"id":2494793,"accession":"0001179110-12-005875","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-12-005875","line_url":"/filing/0001179110-12-005875#line-1","is_derivative":false,"issuer_cik":"0000755806","issuer_name":"PONIARD PHARMACEUTICALS, INC.","issuer_ticker":"PARD","issuer_name_source":null,"issuer_url":"/issuer/0000755806","owner_cik":"0001287535","owner_name":"JACKSON MICHAEL K","owner_display_name":"JACKSON MICHAEL K","owner_url":"/insider/0001287535","role":"Officer (Interim CFO)","role_mark":"O","role_mark_label":"Officer (Interim CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Interim CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":257.0,"shares_display":"257","price_per_share":0.8316,"price_display":"0.83","price_state":"stated","total_value":213.7212,"total_display":"213.72","total_whole":"214","shares_owned_after":5668.0,"shares_owned_after_display":"5,668","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-27","filed_date":"2012-03-27","scope":"insider"},{"id":2717745,"accession":"0001179110-12-003009","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-12-003009","line_url":"/filing/0001179110-12-003009#line-1","is_derivative":false,"issuer_cik":"0000755806","issuer_name":"PONIARD PHARMACEUTICALS, INC.","issuer_ticker":"PARD","issuer_name_source":null,"issuer_url":"/issuer/0000755806","owner_cik":"0001287535","owner_name":"JACKSON MICHAEL K","owner_display_name":"JACKSON MICHAEL K","owner_url":"/insider/0001287535","role":"Officer (Interim CFO)","role_mark":"O","role_mark_label":"Officer (Interim CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Interim CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2401.0,"shares_display":"2,401","price_per_share":0.8679,"price_display":"0.87","price_state":"stated","total_value":2083.8279,"total_display":"2,083.83","total_whole":"2,084","shares_owned_after":5450.0,"shares_owned_after_display":"5,450","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-02-16","filed_date":"2012-02-17","scope":"insider"},{"id":8861125,"accession":"0001179110-11-006476","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-11-006476","line_url":"/filing/0001179110-11-006476#line-1","is_derivative":false,"issuer_cik":"0000755806","issuer_name":"PONIARD PHARMACEUTICALS, INC.","issuer_ticker":"PARD","issuer_name_source":null,"issuer_url":"/issuer/0000755806","owner_cik":"0001287535","owner_name":"JACKSON MICHAEL K","owner_display_name":"JACKSON MICHAEL K","owner_url":"/insider/0001287535","role":"Officer (Interim CFO)","role_mark":"O","role_mark_label":"Officer (Interim CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Interim CFO","security_title":"Common Stock (PARD)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7655.0,"shares_display":"7,655","price_per_share":0.3736,"price_display":"0.37","price_state":"stated","total_value":2859.908,"total_display":"2,859.91","total_whole":"2,860","shares_owned_after":83312.0,"shares_owned_after_display":"83,312","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-04-13","filed_date":"2011-04-14","scope":"insider"},{"id":8922710,"accession":"0001179110-11-000761","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-11-000761","line_url":"/filing/0001179110-11-000761#line-1","is_derivative":false,"issuer_cik":"0000755806","issuer_name":"PONIARD PHARMACEUTICALS, INC.","issuer_ticker":"PARD","issuer_name_source":null,"issuer_url":"/issuer/0000755806","owner_cik":"0001287535","owner_name":"JACKSON MICHAEL K","owner_display_name":"JACKSON MICHAEL K","owner_url":"/insider/0001287535","role":"Officer (Interim CFO)","role_mark":"O","role_mark_label":"Officer (Interim CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Interim CFO","security_title":"Common Stock (PARD)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":44816.0,"shares_display":"44,816","price_per_share":0.5224,"price_display":"0.52","price_state":"stated","total_value":23411.8784,"total_display":"23,411.88","total_whole":"23,412","shares_owned_after":71967.0,"shares_owned_after_display":"71,967","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-01-05","filed_date":"2011-01-07","scope":"insider"},{"id":7321471,"accession":"0001179110-10-002341","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-10-002341","line_url":"/filing/0001179110-10-002341#line-1","is_derivative":false,"issuer_cik":"0000755806","issuer_name":"PONIARD PHARMACEUTICALS, INC.","issuer_ticker":"PARD","issuer_name_source":null,"issuer_url":"/issuer/0000755806","owner_cik":"0001287535","owner_name":"JACKSON MICHAEL K","owner_display_name":"JACKSON MICHAEL K","owner_url":"/insider/0001287535","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3669.0,"shares_display":"3,669","price_per_share":1.6186,"price_display":"1.62","price_state":"stated","total_value":5938.6434,"total_display":"5,938.64","total_whole":"5,939","shares_owned_after":234218.0,"shares_owned_after_display":"234,218","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-02-08","filed_date":"2010-02-09","scope":"insider"},{"id":9241399,"accession":"0001179110-09-016695","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-09-016695","line_url":"/filing/0001179110-09-016695#line-1","is_derivative":false,"issuer_cik":"0000755806","issuer_name":"PONIARD PHARMACEUTICALS, INC.","issuer_ticker":"PARD","issuer_name_source":null,"issuer_url":"/issuer/0000755806","owner_cik":"0001287535","owner_name":"JACKSON MICHAEL K","owner_display_name":"JACKSON MICHAEL K","owner_url":"/insider/0001287535","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":751.0,"shares_display":"751","price_per_share":2.23,"price_display":"2.23","price_state":"stated","total_value":1674.73,"total_display":"1,674.73","total_whole":"1,675","shares_owned_after":4005.0,"shares_owned_after_display":"4,005","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-11-25","filed_date":"2009-12-10","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000755806","name":"PONIARD PHARMACEUTICALS, INC.","url":"/issuer/0000755806","role":"Officer (Interim CFO)","n_filings":6,"first_seen":"2009-12-10","last_seen":"2012-03-27"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001287535","retrieved_at":"2026-08-22T11:46:52+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}